DISEASE INDICATIONS: Psoriasis

MANUFACTURER: Janssen Biotech

USAGE: Subcutaneous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Pharmaceuticals and Medical Devices Agency (PMDA)

Therapeutic Goods Administration (TGA)

Tremfya is a medication with the generic name guselkumab, and it is a biologic therapy used in the treatment of certain autoimmune and inflammatory conditions, primarily psoriasis.